XT
GYRE icon

XTX Topco’s Gyre Therapeutics GYRE Stock Holding History

XTX Topco’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,035
Closed -$66K – 823
2021
Q2 		$66K Buy
+2,035
New +$69.8K 0.02% 705

Other funds holding GYRE

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

XTX Topco's GYRE Position: Q3 2021 in Review

XTX Topco sold out of Gyre Therapeutics (GYRE) in Q3 2021, closing a stake of 2,035 shares — an estimated $66K sold.

XTX Topco first reported a position in GYRE in Q2 2021 and held it in 1 quarter. The position peaked at $66K in Q2 2021. 65 funds tracked by Wall St. Rank hold GYRE as of Q3 2021.

  • XTX Topco reported no remaining Gyre Therapeutics position as of Q3 2021 after selling out during the quarter.
  • XTX Topco sold 2,035 Gyre Therapeutics shares in Q3 2021, an estimated $66K.
  • XTX Topco first reported a position in Gyre Therapeutics in Q2 2021 and held it in 1 quarter.
  • XTX Topco's Gyre Therapeutics position peaked at $66K in Q2 2021.
  • 65 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q3 2021.

Based on XTX Topco's 13F filing for Q3 2021, filed 12 Nov 2021.